Gastrointestinal Cancer News

Divarasib induced durable clinical responses among patients with KRAS G12C-positive solid tumors, according to study findings published in The New England Journal of Medicine.

Use of any benzodiazepine appeared associated with reduced risk for pancreatic cancer-related death, according to study results published in Clinical Cancer Research.

High cardiorespiratory fitness was linked to reductions in head and neck, colon, esophagus, stomach, pancreas, liver, rectum, kidney and lung cancers among men, according to a study published in the British Journal of Sports Medicine.

Surgery appeared underutilized for patients with pancreatic ductal adenocarcinoma, according to study findings published in Journal of Surgical Oncology.

Abstracts of randomized phase 3 clinical trials in gastrointestinal oncology frequently use subjective minimizing language to characterize serious toxicities, according to results of a systematic review presented at ASCO Annual Meeting.

A cancer diagnosis can be terrifying for any patient, but when a colorectal cancer researcher is diagnosed with the same disease that they spent years studying, it also transforms how they practice medicine and how they relate to patients.

The FDA announced several regulatory actions the past few weeks.

Identification of inherited genetic mutations that elevate cancer risk and may be susceptible to targeted therapies has transformed oncology care.

A microsimulation model showed a reduction in colorectal cancer disease burden and mortality when screening for CRC was initiated at ages 45 years or 40 years, which also added life-years to the population at a comparable health care cost.

A review of oncology trials showed approximately two-thirds did not report results on any of three key platforms within 1 year of completion.